131 related articles for article (PubMed ID: 36906739)
21. FDG PET/CT used in identifying adult-onset Still's disease in connective tissue diseases.
Zhou X; Li Y; Wang Q
Clin Rheumatol; 2020 Sep; 39(9):2735-2742. PubMed ID: 32180040
[TBL] [Abstract][Full Text] [Related]
22. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
23. Post transplant lymphoproliferative disease in pediatric solid organ transplant patients: a possible role for [18F]-FDG-PET(/CT) in initial staging and therapy monitoring.
von Falck C; Maecker B; Schirg E; Boerner AR; Knapp WH; Klein C; Galanski M
Eur J Radiol; 2007 Sep; 63(3):427-35. PubMed ID: 17293073
[TBL] [Abstract][Full Text] [Related]
24. FDG PET/CT Findings of Polymorphic Posttransplant Lymphoproliferative Disorders in a Transplanted Kidney.
Yang Y; Wang W; Kan Y; Liu J; Yang J
Clin Nucl Med; 2018 Jun; 43(6):441-444. PubMed ID: 29485445
[TBL] [Abstract][Full Text] [Related]
25. The usefulness of (18)F-FDG PET/CT for assessing methotrexate-associated lymphoproliferative disorder (MTX-LPD).
Watanabe S; Manabe O; Hirata K; Oyama-Manabe N; Hattori N; Kikuchi Y; Kobayashi K; Toyonaga T; Tamaki N
BMC Cancer; 2016 Aug; 16():635. PubMed ID: 27528380
[TBL] [Abstract][Full Text] [Related]
26. 18F-FDG PET for Detection of Primary Tracheobronchial T-/Natural Killer-Cell-Derived Posttransplant Lymphoproliferative Disorder After Lung Transplantation.
Derlin T; Braubach P; Kreipe HH; Hueper K
Clin Nucl Med; 2017 Dec; 42(12):988-989. PubMed ID: 29076909
[TBL] [Abstract][Full Text] [Related]
27. FDG uptake in cervical lymph nodes in children without head and neck cancer.
Vali R; Bakkari A; Marie E; Kousha M; Charron M; Shammas A
Pediatr Radiol; 2017 Jun; 47(7):860-867. PubMed ID: 28357549
[TBL] [Abstract][Full Text] [Related]
28. Predictive Value of 18F-FDG PET/CT for Vascular Invasion in Patients With Hepatocellular Carcinoma Before Liver Transplantation.
Lin CY; Liao CW; Chu LY; Yen KY; Jeng LB; Hsu CN; Lin CL; Kao CH
Clin Nucl Med; 2017 Apr; 42(4):e183-e187. PubMed ID: 28114226
[TBL] [Abstract][Full Text] [Related]
29. Post-transplant lymphoproliferative disorder of the pediatric airway: Presentation and management.
O'Neill AF; Adil EA; Irace AL; Neff L; Davis IJ; Perez-Atayde AR; Voss SD; Weinberg O; Rahbar R
Int J Pediatr Otorhinolaryngol; 2016 Jul; 86():218-23. PubMed ID: 27260610
[TBL] [Abstract][Full Text] [Related]
30. The role of 18F-FDG PET/CT in the evaluation of pediatric transplant patients.
Yang J; Zhuang H
Hell J Nucl Med; 2015; 18(2):136-9. PubMed ID: 26187213
[TBL] [Abstract][Full Text] [Related]
31. Prediction of ultrasound guided fine needle aspiration cytology results by FDG PET-CT for lymph node metastases in head and neck squamous cell carcinoma patients.
Peltenburg B; de Keizer B; Dankbaar JW; de Boer M; Willems SM; Philippens MEP; Terhaard CHJ; de Bree R
Acta Oncol; 2018 Dec; 57(12):1687-1692. PubMed ID: 30489180
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of Dual-Timepoint
Collarino A; Garganese G; Valdés Olmos RA; Stefanelli A; Perotti G; Mirk P; Fragomeni SM; Ieria FP; Scambia G; Giordano A; Rufini V
J Nucl Med; 2017 Dec; 58(12):1913-1918. PubMed ID: 28546331
[TBL] [Abstract][Full Text] [Related]
33. A diagnostic model based on
Zhou S; Tsui P; Lin M; Chen G; Chen W; Cai X
BMC Med Imaging; 2024 Jan; 24(1):14. PubMed ID: 38191331
[TBL] [Abstract][Full Text] [Related]
34. Detection of bone marrow involvement in newly diagnosed post-transplant lymphoproliferative disorder: (18)F-fluorodeoxyglucose positron emission tomography/computed tomography versus bone marrow biopsy.
Gheysens O; Thielemans S; Morscio J; Boeckx N; Goffin KE; Deroose CM; Sagaert X; Wlodarska I; Verhoef G; Dierickx D; Tousseyn T
Leuk Lymphoma; 2016 Oct; 57(10):2382-8. PubMed ID: 26854937
[TBL] [Abstract][Full Text] [Related]
35. Preliminary experience on the use of PET/CT in the management of pediatric post-transplant lymphoproliferative disorder.
Guerra-García P; Hirsch S; Levine DS; Taj MM
Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28612477
[TBL] [Abstract][Full Text] [Related]
36. The accuracy of positron emission tomography in the detection of posttransplant lymphoproliferative disorder.
Dierickx D; Tousseyn T; Requilé A; Verscuren R; Sagaert X; Morscio J; Wlodarska I; Herreman A; Kuypers D; Van Cleemput J; Nevens F; Dupont L; Uyttebroeck A; Pirenne J; De Wolf-Peeters C; Verhoef G; Brepoels L; Gheysens O
Haematologica; 2013 May; 98(5):771-5. PubMed ID: 23065524
[TBL] [Abstract][Full Text] [Related]
37. Assessing
Sarikaya I; Sarikaya A
J Nucl Med Technol; 2019 Jun; 47(2):149-153. PubMed ID: 30413593
[No Abstract] [Full Text] [Related]
38. Positron emission tomography scanning in the setting of post-transplant lymphoproliferative disorders.
Blaes AH; Cioc AM; Froelich JW; Peterson BA; Dunitz JM
Clin Transplant; 2009; 23(6):794-9. PubMed ID: 20447185
[TBL] [Abstract][Full Text] [Related]
39. Correlation Between
Yu P; Lei J; Xu B; Wang R; Shen Z; Tian J
Acad Radiol; 2020 May; 27(5):682-688. PubMed ID: 31311773
[TBL] [Abstract][Full Text] [Related]
40. Improved detection of metastatic lymph nodes in oesophageal squamous cell carcinoma by combined interpretation of fluorine-18-fluorodeoxyglucose positron-emission tomography/computed tomography.
Lee JY; Kim YH; Park YJ; Park SB; Chung HW; Zo JI; Shim YM; Lee KS; Choi JY
Cancer Imaging; 2019 Jun; 19(1):40. PubMed ID: 31227017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]